pubmed-article:7822155 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C0042776 | lld:lifeskim |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C0087048 | lld:lifeskim |
pubmed-article:7822155 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:7822155 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:7822155 | pubmed:dateCreated | 1995-2-14 | lld:pubmed |
pubmed-article:7822155 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7822155 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7822155 | pubmed:abstractText | To understand better the immunopathology of HTLV-I uveitis by investigating the clonality of HTLV-I-infected T-cell clones. | lld:pubmed |
pubmed-article:7822155 | pubmed:language | eng | lld:pubmed |
pubmed-article:7822155 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7822155 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7822155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7822155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7822155 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7822155 | pubmed:month | Jan | lld:pubmed |
pubmed-article:7822155 | pubmed:issn | 0146-0404 | lld:pubmed |
pubmed-article:7822155 | pubmed:author | pubmed-author:MochizukiMM | lld:pubmed |
pubmed-article:7822155 | pubmed:author | pubmed-author:ItohKK | lld:pubmed |
pubmed-article:7822155 | pubmed:author | pubmed-author:SagawaKK | lld:pubmed |
pubmed-article:7822155 | pubmed:author | pubmed-author:OizumiKK | lld:pubmed |
pubmed-article:7822155 | pubmed:author | pubmed-author:MasuokaKK | lld:pubmed |
pubmed-article:7822155 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7822155 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:7822155 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7822155 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7822155 | pubmed:pagination | 254-8 | lld:pubmed |
pubmed-article:7822155 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:meshHeading | pubmed-meshheading:7822155-... | lld:pubmed |
pubmed-article:7822155 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:7822155 | pubmed:articleTitle | Polyclonal use of T-cell receptor alpha for human T-cell lymphotropic virus type 1-infected T cells. | lld:pubmed |
pubmed-article:7822155 | pubmed:affiliation | Department of Immunology, Kurume University School of Medicine, Japan. | lld:pubmed |
pubmed-article:7822155 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7822155 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |